Kiniksa Pharmaceuticals International, plc Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Kiniksa Pharmaceuticals International, plc (KNSA) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $983.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-24
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $983.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.29M.
- 2023-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.12M.
- 2023-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.30M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $983.00K 10-K · filed 2026-02-24 |
| 2024-12-31 | $1.29M 10-K · filed 2025-02-25 |
| 2023-09-30 | $2.12M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.30M 10-Q · filed 2023-08-01 |
| 2022-12-31 | $271.00K 10-K · filed 2023-03-02 |
| 2021-12-31 | $284.00K 10-K · filed 2022-02-24 |
| 2020-12-31 | $554.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $46.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $64.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $98.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | $141.00K 10-K · filed 2020-03-05 |
| 2019-09-30 | $190.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $245.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $307.00K 10-Q · filed 2019-05-07 |